ATE333504T1 - Polymorphismen in der promoterregion des humanen cyp2d6 gens und deren diagnostische und therapeutische verwendung - Google Patents

Polymorphismen in der promoterregion des humanen cyp2d6 gens und deren diagnostische und therapeutische verwendung

Info

Publication number
ATE333504T1
ATE333504T1 AT01946895T AT01946895T ATE333504T1 AT E333504 T1 ATE333504 T1 AT E333504T1 AT 01946895 T AT01946895 T AT 01946895T AT 01946895 T AT01946895 T AT 01946895T AT E333504 T1 ATE333504 T1 AT E333504T1
Authority
AT
Austria
Prior art keywords
polymorphisms
diagnostic
cyp2d6 gene
promoter region
therapeutic use
Prior art date
Application number
AT01946895T
Other languages
English (en)
Inventor
Sebastian Raimundo
Ulrich Zanger
Original Assignee
Epidauros Biotechnologie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidauros Biotechnologie Ag filed Critical Epidauros Biotechnologie Ag
Application granted granted Critical
Publication of ATE333504T1 publication Critical patent/ATE333504T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01946895T 2000-01-31 2001-01-30 Polymorphismen in der promoterregion des humanen cyp2d6 gens und deren diagnostische und therapeutische verwendung ATE333504T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00101889 2000-01-31

Publications (1)

Publication Number Publication Date
ATE333504T1 true ATE333504T1 (de) 2006-08-15

Family

ID=8167736

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01946895T ATE333504T1 (de) 2000-01-31 2001-01-30 Polymorphismen in der promoterregion des humanen cyp2d6 gens und deren diagnostische und therapeutische verwendung

Country Status (9)

Country Link
US (2) US8129112B2 (de)
EP (1) EP1276880B1 (de)
JP (1) JP2004506405A (de)
AT (1) ATE333504T1 (de)
AU (1) AU2001257913A1 (de)
CA (1) CA2398104C (de)
DE (1) DE60121567T2 (de)
ES (1) ES2267787T3 (de)
WO (1) WO2001055432A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021286D0 (en) * 2000-08-30 2000-10-18 Gemini Genomics Ab Identification of drug metabolic capacity
JP2008504826A (ja) * 2004-06-30 2008-02-21 ティーエム バイオサイエンス ピージーエクス インコーポレイティッド チトクロムp450−2d6をコードする遺伝子における変異を検出する方法
GB0614396D0 (en) * 2006-07-20 2006-08-30 Knox Geoffrey M Test for the presence of active CYP450 2D6
CN114317533B (zh) * 2022-01-12 2023-08-29 武汉艾迪康医学检验所有限公司 一组探针和利用杂交捕获法检测药物基因组学相关基因cyp2d6多态性的建库试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433180T2 (de) * 1993-10-26 2004-06-24 Affymetrix, Inc., Santa Clara Felder von nukleinsaeuresonden auf biologischen chips
WO2001096604A2 (en) * 2000-06-12 2001-12-20 Genicon Sciences Corporation Assay for genetic polymorphisms using scattered light detectable labels

Also Published As

Publication number Publication date
DE60121567T2 (de) 2007-07-05
US20040224424A1 (en) 2004-11-11
JP2004506405A (ja) 2004-03-04
CA2398104C (en) 2015-03-10
DE60121567D1 (de) 2006-08-31
EP1276880A2 (de) 2003-01-22
ES2267787T3 (es) 2007-03-16
AU2001257913A1 (en) 2001-08-07
EP1276880B1 (de) 2006-07-19
CA2398104A1 (en) 2001-08-02
US8129112B2 (en) 2012-03-06
WO2001055432A2 (en) 2001-08-02
WO2001055432A3 (en) 2002-10-31
US20120270948A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
EP2154157A3 (de) Varianten der Fc Region
WO2005059106A3 (en) Interferon alpha antibodies and their uses
CY1112953T1 (el) Χρηση των αντι-cd100 αντισωματων
ATE318328T1 (de) Diagnostika und therapeutika für osteoporose
EA200601074A1 (ru) Применение производных пептидов для лечения болей, связанных с заболеванием центральной нервной системы (центральной невропатической боли)
ATE455185T1 (de) Atypische protein-kinase-c-isoformen bei erkrankungen des nervensystems und krebs
WO2002081745A3 (en) Genes involved in osteogenesis, and methods of use
DE60121567D1 (de) Polymorphismen in der promoterregion des humanen cyp2d6 gens und deren diagnostische und therapeutische verwendung
WO2002060375A3 (en) Diphenyl ether derivatives and their uses as heparanase inhibitors
CY1107437T1 (el) Νεα πολυπεπτιδια kcnq και οι χρησεις τους στη διαγνωση διανοητικων διαταραχων
ATE378423T1 (de) Polymorphismen des menschlichen hpxr gens und ihre anwendung in diagnose und therapie
ATE328077T1 (de) Gen assoziiert mit iga glomerulonephritis
ATE431855T1 (de) Menschliches autismus-suszeptibilitätsgen und verwendungen davon
WO2005118865A3 (en) Diagnosis and treatment of drug resistant leukemia
WO2003038130A3 (en) Therapeutics and diagnostics for disorders of erythropoiesis
WO2006046270A3 (en) Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
MXPA03010728A (es) Moleculas de proteina-2 relacionadas con b7 y uso de las mismas.
WO2006003523A8 (en) Human autism susceptibility gene encoding prkcb1 and uses thereof
WO2005014804A3 (en) Ubiquitin-specific protease
WO2006087634A3 (en) Uses of human autism susceptibility gene encoding a kinase
JP2004506405A5 (de)
WO2006090288A3 (en) Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof
WO1999040220A3 (en) Method of screening therapeutic agents
DE60222669D1 (de) Asthma-assoziiertes gen
EP0854186A3 (de) Zellteilungs-Gen DivIB von Staphylococcus aureus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1276880

Country of ref document: EP